Business
Stem Cells Shows Promise For Repairing Torn Meniscus
Stem Cells Shows Promise For Repairing Torn Meniscus.
About this update from U.s. Stem Cell, Inc.
[{"type":"text","content":"\n\n\n\nStem Cells Shows Promise For Repairing Torn Meniscus\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nStem Cells Shows Promise For Repairing Torn Meniscus\nUSRM Chief Science Officer Publishes Findings in Peer-Reviewed Scientific Literature\nPR Newswire\nSUNRISE, Fla., July 10, 2018\n\n\n\n\n \n\n \n\n\n\n\nSUNRISE, Fla., July 10, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has demonstrated successful, in-human results in repairing meniscus tear after autologous stem cell therapy from adipose or fat tissue.  \n\nResults are published in the scientific publication the Journal of Medical Cases, and is authored by USRM Chief Science Officer Dr. Kristin Comella and colleagues Dr. Scott Greenberg of the Magaziner Center for Wellness, and Dr. Laura Ross of Ross Orthopedic.\n\n\"The ability to provide this kind of therapy to Americans can be life changing,\" said Dr. Comella.  \"Use of one's own healing cells to help repair damaged tissue rather than having to cut open or manipulate the damaged area to try to reduce pain and restore function is the most elegant form of regenerative medicine we have today.\"\n\nMeniscal injuries are the most common knee injury in the United States with an annual average of incidence of 66 per 100,000, according to a 2014 article in the Journal of Orthopedics.  Approximately 850,000 patients each year are surgically treated -- often arthroscopically -- for meniscal injuries.  \n\nThe paper outlines the case study of a 56-year-old male with a chronic meniscus injury.  During the 12-month follow-up period, the patient reported a reduction in pain and an improvement in knee function. Figure 1a shows a tear at baseline on the posterior horn of the medial meniscus, while Figure 1b, taken 9 months after the first injection shows complete resolution of the tear. The healed tear could not be penetrated by the probe. \n\nThe arthroscopic images showing resolution were ...